Therapeutic Mechanisms and Clinical Effects of Glucagon-like Peptide 1 Receptor Agonists in Nonalcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease (NAFLD) can lead to liver fibrosis and cirrhosis. Recently, glucagon-like peptide 1 receptor agonists (GLP-1RAs), a class of drugs used to treat type 2 diabetes and obesity, have shown therapeutic effects against NAFLD. In addition to reducing blood glucose levels an...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Han Ah, Kim, Hwi Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253495/
https://www.ncbi.nlm.nih.gov/pubmed/37298276
http://dx.doi.org/10.3390/ijms24119324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253495/
https://www.ncbi.nlm.nih.gov/pubmed/37298276
http://dx.doi.org/10.3390/ijms24119324

Ejemplares similares